Hims & Hers News and Activities

Hims & Hers is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Hims & Hers is a company listed under the stock ticker HIMS (US).

View the org chart displaying its 38 main executives

Most searched biographies at Hims & Hers

• Andrew Dudum, Director and Chief Executive Officer
• David Wells, Director
• Andrea Perez, Director

Popular executive movements at Hims & Hers

• Mohamed Elshenawy has joined the company as Chief Technology Officer  (posted on May 8 2025).
• Nader Kabbani has joined the company as Chief Operations Officer  (posted on May 6 2025).
• Janet Stevens has joined the company as Global Head of Quality & Safety  (posted on November 19 2024).

Click here to view some more movements at Hims & Hers

Create your alert
to follow the executive moves at Hims & Hers.

Hims & Hers has 1,825 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• Danone has announced the acquisition of Kate Farms  (posted on May 14 2025).
• Cyclo Therapeutics has acquired Rafael Holdings (posted on April 28 2025).
• Chimerix and Chimerix have merged  (posted on April 22 2025)..

Popular contacts in Pharmaceuticals

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets at Bristol-Myers Squibb
• Seth Harrison - Chairman and Director at Braeburn Pharmaceuticals
• Fred Davenport - Lead Director at Medpace

Learn more about the Pharmaceuticals industry

Press releases by Hims & Hers

• Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
• Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
• Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
• Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
• Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
• Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
• Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
• Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
• Hims & Hers Acquires US-based Peptide Facility
• Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
• View more press releases Close

Social media about Hims & Hers

• Hims & Hers on Wikipedia, Google News & Yahoo Finance
• Hims & Hers on LinkedIn, Twitter & YouTube